Thylakoids for Health & Longevity - Quick Reference Sheet

Thylakoids for Health & Longevity

Created on 09/28/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / GPT 6 – Audit

Thylakoids are plant membranes concentrated into oral spinach supplements for appetite and weight management. Short-term hunger and fullness are the clearest benefits; weight, cholesterol, and glucose findings are inconsistent. For adults with strong nutrition and exercise habits, possible appetite support is the main value. Longer lifespan and disease prevention remain unproven. Long-term safety and interactions are uncertain; reduced intake may compromise nutrition and muscle. (Full Review)

Protocol

Usual research dose
5 g/day for 12 weeks
Concentrated thylakoid-rich spinach extract mass, not pure membranes; research use, no established longevity regimen.
Timing
Before breakfast or lunch
Before breakfast or roughly 30 minutes before lunch; no superior time established.
Single versus divided doses
Usually once-daily powder
One trial divided capsules between breakfast and lunch; comparative superiority unknown.
Time to effect
Short-term hunger and fullness
Within hours
Hunger ratings can change; acute fullness does not establish sustained fat loss.
Weight and body-fat management
Weeks to months
Body-weight trial evaluation period; benefit remains inconsistent.

Benefits

Contraindications
  • Known allergy to spinach or another product ingredient
  • Pregnancy, breastfeeding, children (supplemental doses)
  • Underweight (body mass index below 18.5 kg/m²), active eating disorders, undernutrition, ongoing unintentional weight loss
Key Interactions
  • Ciprofloxacin (calcium-containing extract; human effects untested)
  • Mineral-sensitive medicines (doxycycline, levothyroxine, alendronate; relevant minerals present; extract-specific effects untested)
  • Warfarin (variable residual vitamin K; untested concern)
  • Insulin, sulfonylureas (glipizide; reduced food intake; additive effects untested)
  • Appetite-hormone medicines (semaglutide), orlistat (including over-the-counter); combinations untested
  • Psyllium, glucomannan, berberine (combinations untested)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Headache reported during trials; Nausea during meal testing; Allergy to residual spinach proteins; Unfavorable glucose response after meals
  • Speculative: Impaired nutrient absorption; Reduced oral drug exposure; Inadequate energy intake; Product-dependent spinach constituents

Monitoring

Marker Target Why
Body weight and waist No established thylakoid-specific target; baseline and intended change Assess sustained effect
Fasting glucose80–89 mg/dL (Kresser’s practitioner preference; not a universal treatment target)Detect glucose change
HbA1c4.6–5.3% (Kresser’s practitioner range)Longer-term glucose context; average blood glucose
Lipid panelNo established extract-specific optimal range; individual risk-based targetsAssess lipid signal
Nutrient statusNo established supplement-specific target; baseline and restricted intakeDetect nutritional compromise; testing by clinical context
Warfarin clotting testNo established thylakoid-specific target; prescribed therapeutic rangeDetect altered anticoagulation; warfarin users only

Cadence: Baseline measures; symptoms/intake at 1–2 weeks; weekly weight trends, monthly weight/waist; relevant blood tests at 12 weeks. Pragmatic, not trial-validated. Warfarin: prescriber-defined checks after changes. No thylakoid-specific laboratory target is established; practitioner ranges are not proven longevity targets.

Qualitative Assessment

  • Appetite and cravings: Ratings at consistent meals/times.
  • Energy and strength: Meal completion, exercise performance, unintended fatigue.
  • Tolerance: Digestive symptoms, headache, skin reactions, intake changes.